Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates

Array BioPharma to Be Acquired by Pfizer

Skadden is advising Array BioPharma Inc. on its acquisition by Pfizer Inc. for a total enterprise value of approximately $11.4 billion.
BACK TO TOP